In addition, several disease pathways including the ‘endometrial cancer, ‘colorectal cancer’, ‘ErbB signaling’, ‘breast cancer’, and ‘gastric cancer’ pathways with Kras, Gsk3b, and Raf1 genes were significantly enriched (Table 3). This evidence concerns the gene KRAS and endometrial cancer.